Stock Market Stories and Insights

TGA
  a day ago at Macroaxis 
By Raphi Shpitalnik
The stock is undergoing an active downward rally. As many baby boomers are still indifferent towards energy space, it makes sense to go over Transglobe Energy Cp as a unique choice for millenniums. What exactly are Transglobe Energy shareholders getting in November? Here we also measure the ability of Transglobe Energy to meet its long-term debt obligations, such as interest payments on debt, the final principal payment on the debt, and any other fixed obligations like lease payments.
MOXC
  a day ago at Macroaxis 
By Vlad Skutelnik
As many of us are excited about technology space, it is fair to go over Moxian Bvi within current market trends. Even if we see continued slowdown in the economy, Moxian Bvi may be more resilient than the broader market in the long run. The returns on the market and returns on Moxian Bvi appear slightly correlated for the last few months. Strong basic indicators of the company may also suggest signals of long term gains for Moxian investors. The upcoming quarterly report is expected on the 12th of November 2021. The stock is undergoing an active downward rally.
ANVS
  a day ago at Macroaxis 
By Ellen Johnson
Biocardia would recover faster from the current slip as its shares price went up 2.98% to Annovis Bio's 9.15%As many of us are excited about healthcare space, we will review both, Annovis Bio and Biocardia as a potential short-term opportunity. We are going to discuss some of the competitive aspects of both Annovis and Biocardia.
GOTU
  a day ago at Macroaxis 
By Raphi Shpitalnik
Gaotu Techedu Tangible Assets Book Value per Share are comparatively stable at the moment as compared to the past year. Gaotu Techedu reported Tangible Assets Book Value per Share of 44.48 in 2020. Depreciation Amortization and Accretion is likely to gain to about 60.2 M in 2021, whereas Current Ratio is likely to drop 1.68 in 2021. While some baby boomers are getting worried about consumer defensive space, it is reasonable to review Gaotu Techedu. What exactly are Gaotu Techedu shareholders getting in November? This post is to show some fundamental factors affecting Gaotu Techedu's products and services. I will also uncover how it may impact the investing outlook for Gaotu Techedu in November.
PDSB
  a day ago at Macroaxis 
By Ellen Johnson
It looks like Regeneron Pharmaceuticals will be up for a correction faster as its share price went up 0.43% today to Pds Biotechnology's 9.34%As many rational traders are trying to avoid healthcare space, it makes sense to go over Pds Biotechnology Corp a little further and understand how it stands against Regeneron Pharmaceuticals and other similar entities. We are going to analyze some of the competitive aspects of both Pds Biotechnology and Regeneron.
AMTI
  a day ago at Macroaxis 
By Vlad Skutelnik
The upcoming quarterly report is expected on the 11th of November 2021. The stock goes through an active downward rally. While some baby boomers are getting worried about healthcare space, it is reasonable to concentrate on Applied Molecular Transport as an investment alternative. What exactly are Applied Molecular shareholders getting in November?
AMTI
  a day ago at Macroaxis 
By Vlad Skutelnik
It seems as Applied Molecular may not have a good chance to recover from the current drop as its shares fell again. The firm current daily volatility is 3.26 percent, with a beta of 1.01 and an alpha of -0.82 over DOW. As many millenniums are trying to avoid the current volatility, we are going to concentrate on Applied Molecular Transport a little further to understand its historical price patterns. We will analyze why it could be a much better year for Applied Molecular shareholders.
CVAC
  a day ago at Macroaxis 
By Raphi Shpitalnik
In general, we focus on analyzing Curevac (NASDAQ:CVAC) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Curevac NV daily price indicators and compare them against related drivers. Today's article will go over Curevac NV. We will analyze why it could be a much better year for Curevac NV shareholders.
FUTU
  a day ago at Macroaxis 
By Vlad Skutelnik
Futu Holdings Book Value per Share is comparatively stable at the moment as compared to the past year. Futu Holdings reported Book Value per Share of 64.10 in 2020. Current Ratio is likely to gain to 0.82 in 2021, whereas Sales per Share is likely to drop 2.62 in 2021. While some of us are becoming more passionate about trading space, it makes sense to review Futu Holdings in greater detail. I will take a closer look at this stock and the newest sentiment generated by private investors. In this post, I will also go over a few different drivers affecting Futu Holdings' products and services, and explain how it may impact Futu Holdings private investors.
OCGN
  a day ago at Macroaxis 
By Vlad Skutelnik
In this post we will outline Ocugen. I will address few reasons this entity was abused by institutional investors due to the current market volatility. Ocugen Inc is now traded for 8.66. The entity has historical hype elasticity of -0.02. The average price elasticity to hype of competition is about 1.71. The firm is forecasted to decline in value after the next headline, with the price expected to drop to 8.64. The average volatility of media hype impact on the company stock price is huge, making predictions on the news or social media along less reliable. The price decrease on the next news is expected to be -0.23%, whereas the daily expected return is now at 0.35 percent. The volatility of related hype on Ocugen is about 109.02% with expected price after next announcement by competition of 10.37 Given the investment horizon of 90 days the next forecasted press release will be in about 10 days.